CSRxP Statement On HHS DTC Advertising Announcement
Oct 15, 2018
CSRxP issued the following statement in response to the U.S. Department of… Read More
© 2025 CSRXP- All Rights Reserved
Press Release
CSRxP Statement On PhRMA’s DTC Advertising Announcement
Oct 15, 2018
The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement… Read More
Congress Rejects Big Pharma Bailout
Sep 26, 2018
Defeat For Price-Gouging Drug Manufacturers; Victory For Taxpayers &… Read More
CSRxP Urges Congress to Stop Big Pharma’s $4 Billion Bailout
Sep 25, 2018
Washington, D.C. – Today the Campaign for Sustainable Rx Pricing… Read More
CSRxP Urges House Members To Maintain Transparency Provision In Senate-Passed Appropriations Bill
Aug 29, 2018
CSRxP-Supported Policy Enables HHS To Require Drug Price Disclosure In… Read More
CSRxP Applauds Senate Action To Boost Drug Price Transparency For Consumers
Aug 24, 2018
Legislation Includes CSRxP-Supported Amendment Enabling HHS To Require… Read More
Statement on Celgene’s Revlimid Price Hike
Jul 10, 2018
CSRxP spokesman Will Holley released the following statement in response to… Read More
CSRxP Applauds Secretary Azar’s Focus on List Prices
Jun 26, 2018
CSRxP spokesman Will Holley released the following statement in response to… Read More
CSRxP Testimony for the Record: Senate Finance Committee Hearing on Rx Prices
Jun 25, 2018
The Campaign for Sustainable Rx Pricing today released testimony for the… Read More
CSRxP Applauds Senate Judiciary Committee for Vote on CREATES Act
Jun 14, 2018
“We applaud the members of the Senate Judiciary Committee for voting the… Read More
CSRxP Statement on Secretary Azar’s Testimony in Front of Senate HELP Committee
Jun 12, 2018
“When the manufacturer-set price of a drug starts out high… Read More
46 Signatories Applaud Grassley & Feinstein for CREATES Act Markup
Jun 7, 2018
46 organizations today applauded Chairman Chuck Grassley and Ranking Member… Read More